Skip to Main Content

Author Details

Adam Foye
University of California San Francisco
2003
25
16
PMIDPaper TitleJournal TitlePublished Year
37289025The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer.Cancer Res2023
36251389The 5-Hydroxymethylcytosine Landscape of Prostate Cancer.Cancer Res2022
36109521Transcriptional profiling of matched patient biopsies clarifies molecular determinants of enzalutamide-induced lineage plasticity.Nat Commun2022
32286548Clinical and genomic characterization of Low PSA Secretors: a unique subset of metastatic castration resistant prostate cancer.Prostate Cancer Prostatic Dis2021
34554200Prognosis Associated With Luminal and Basal Subtypes of Metastatic Prostate Cancer.JAMA Oncol2021
32424106Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistance.Proc Natl Acad Sci U S A2020
31745256Germline polymorphisms associated with impaired survival outcomes and somatic tumor alterations in advanced prostate cancer.Prostate Cancer Prostatic Dis2020
32624423Down-regulation of ADRB2 expression is associated with small cell neuroendocrine prostate cancer and adverse clinical outcomes in castration-resistant prostate cancer.Urol Oncol2020
32727885Copy Number Loss of 17q22 Is Associated with Enzalutamide Resistance and Poor Prognosis in Metastatic Castration-Resistant Prostate Cancer.Clin Cancer Res2020
30928160Genomic Drivers of Poor Prognosis and Enzalutamide Resistance in Metastatic Castration-resistant Prostate Cancer.Eur Urol2019
30804427MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancer.Prostate Cancer Prostatic Dis2019
30918106Whole-Genome and Transcriptional Analysis of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer Demonstrates Intraclass Heterogeneity.Mol Cancer Res2019
30340047Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer.Cell2018
29985747Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study.J Clin Oncol2018
30033370Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer.Cell2018
28549709CT-Guided Bone Biopsies in Metastatic Castration-Resistant Prostate Cancer: Factors Predictive of Maximum Tumor Yield.J Vasc Interv Radiol2017
28450426Analysis of Circulating Cell-Free DNA Identifies Multiclonal Heterogeneity of <i>BRCA2</i> Reversion Mutations Associated with Resistance to PARP Inhibitors.Cancer Discov2017
29206995Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer.J Natl Cancer Inst2017
27343980An improved CTC isolation scheme for pairing with downstream genomics: Demonstrating clinical utility in metastatic prostate, lung and pancreatic cancer.Cancer Lett2016
24366412Successful whole-exome sequencing from a prostate cancer bone metastasis biopsy.Prostate Cancer Prostatic Dis2014
23925271Bone marrow biopsy: RNA isolation with expression profiling in men with metastatic castration-resistant prostate cancer--factors affecting diagnostic success.Radiology2013
19882268Cancer gene profiling in prostate cancer.Methods Mol Biol2010
19773438MYC activity mitigates response to rapamycin in prostate cancer through eukaryotic initiation factor 4E-binding protein 1-mediated inhibition of autophagy.Cancer Res2009
15886399Inhibition of surfactant activity by Pneumocystis carinii organisms and components in vitro.Am J Physiol Lung Cell Mol Physiol2005
12902318Surface activity of a synthetic lung surfactant containing a phospholipase-resistant phosphonolipid analog of dipalmitoyl phosphatidylcholine.Am J Physiol Lung Cell Mol Physiol2003
  • 1 - 25 of 25

Recommended Authors

Sinja Taavitsainen
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 2018
Number of shared co-authors 9
Michael Sigouros
Caryl and Israel Englander Institute for Precision Medicine
Career Start Year 2017
Number of shared co-authors 13
Natalie Kurganovs
Australian Prostate Cancer Research Centre Epworth
Career Start Year 2015
Number of shared co-authors 3
Wei Yuan
The Institute for Cancer Research
Career Start Year 2015
Number of shared co-authors 13
Joshua Armenia
Oncology R&D
Career Start Year 2013
Number of shared co-authors 17
Nicholas Erho
GenomeDx Biosciences Inc.
Career Start Year 2012
Number of shared co-authors 26
Julie Livingstone
University of California los angeles
Career Start Year 2011
Number of shared co-authors 15
Mandeep Takhar
GenomeDx Biosciences Inc.
Career Start Year 2010
Number of shared co-authors 21
Adam G Sowalsky
National Cancer Institute
Career Start Year 2010
Number of shared co-authors 16
Mohammed Alshalalfa
University of Miami Miller School of Medicine/Sylvester Comprehensive Cancer Center
Career Start Year 2009
Number of shared co-authors 32
Anne Haegert
University of British Columbia
Career Start Year 2008
Number of shared co-authors 18
Susana Miranda
The Institute of Cancer Research
Career Start Year 2008
Number of shared co-authors 15
Mark M Pomerantz
Dana-Farber Cancer Institute
Career Start Year 2007
Number of shared co-authors 24
Robert J Lonigro
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2007
Number of shared co-authors 18
Tamara L Lotan
Johns Hopkins University School of Medicine
Career Start Year 2006
Number of shared co-authors 28
Elai Davicioni
Veracyte Inc.
Career Start Year 2006
Number of shared co-authors 44
Alok K Tewari
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2005
Number of shared co-authors 7
Mitchell G Lawrence
Biomedicine Discovery Institute, Monash University
Career Start Year 2005
Number of shared co-authors 6
Robert H Bell
University of British Columbia
Career Start Year 2004
Number of shared co-authors 15
Christopher E Barbieri
Weill Cornell Medical College
Career Start Year 2003
Number of shared co-authors 20
Heather H Cheng
Fred Hutchinson Cancer Center, University of Washington
Career Start Year 2002
Number of shared co-authors 28
Ladan Fazli
University of British Columbia
Career Start Year 2002
Number of shared co-authors 32
Wassim Abida
Memorial Sloan Kettering Cancer Center
Career Start Year 2002
Number of shared co-authors 26
Tarek A Bismar
University of Calgary Cumming School of Medicine, Rockyview General Hospital
Career Start Year 2002
Number of shared co-authors 16
Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year 2001
Number of shared co-authors 11
Xuhong Cao
Michigan Center for Translational Pathology.
Career Start Year 1999
Number of shared co-authors 19
Hayley C Whitaker
University College London
Career Start Year 1999
Number of shared co-authors 4
Srinivasan Yegnasubramanian
Johns Hopkins University School of Medicine
Career Start Year 1999
Number of shared co-authors 11
Rosina T Lis
National Cancer Institute
Career Start Year 1992
Number of shared co-authors 20
George Steven Bova
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 1982
Number of shared co-authors 12

Collaborators

Eric J Small
University of California san francisco
Co-authored papers 19
Rahul Aggarwal
University of California San Francisco
Co-authored papers 18
Joshi J Alumkal
Rogel Cancer Center, University of Michigan ann arbor
Co-authored papers 17
Tomasz M Beer
OHSU Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 16
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers 16
Martin E Gleave
University of British Columbia
Co-authored papers 15
Matthew B Rettig
David Geffen School of Medicine, University of California los angeles
Co-authored papers 14
Christopher P Evans
University of California Davis
Co-authored papers 14
Jiaoti Huang
Duke University School of Medicine
Co-authored papers 14
Robert E Reiter
David Geffen School of Medicine at university of california los angeles
Co-authored papers 13
David A Quigley
University of California-San Francisco
Co-authored papers 12
Kim N Chi
University of British Columbia
Co-authored papers 10
Primo N Lara
University of California Davis Comprehensive Cancer Center
Co-authored papers 10
Joshua M Stuart
University of California at Santa Cruz
Co-authored papers 9
Paul Lloyd
Bluestar Genomics Inc.
Co-authored papers 8
Owen N Witte
University of California los angeles
Co-authored papers 8
Thomas J George
UF Health Cancer Center
Co-authored papers 7
George V Thomas
Knight Cancer Institute, Oregon Health and Science University
Co-authored papers 7
Alana S Weinstein
University of California San Francisco
Co-authored papers 7
Phillip G Febbo
Illumina Inc.
Co-authored papers 6
Alexander W Wyatt
University of British Columbia
Co-authored papers 6
Eric Lu
David Geffen School of Medicine at university of california los angeles
Co-authored papers 4
Haolong Li
University of California san francisco
Co-authored papers 4
Jonathan Chou
University of California san francisco
Co-authored papers 4
Christopher A Maher
Washington University in St Louis
Co-authored papers 4
Marc D Perry
Ontario Institute for Cancer Research
Co-authored papers 4
Theodore C Goldstein
Bakar Computational Health Sciences Institute, University of California san francisco
Co-authored papers 3
Daniel E Spratt
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 3
Martin Sj??str??m
University of California-San Francisco
Co-authored papers 3
Lawrence Fong
University of California san francisco
Co-authored papers 3
Release 1.2